SCR-LIP-000151 · Claim · machine-readable JSON →
In a study of women with lipedema (mean BMI 28.9) versus controls, lipedema patients showed a favorable plasma lipid profile (HDL 1.65 vs 1.04 mmol/L, p<0.0001; lower LDL:HDL and triglyceride:HDL ratios) and preserved metabolic indices (no difference in fasting glucose, insulin, or HOMA-IR), despite stage-dependent adipocyte hypertrophy, interstitial fibrosis, and inflammatory changes in affected thigh subcutaneous adipose tissue.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-06-12
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis — Kruppa et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
The article reports a favorable lipid profile and preserved metabolic parameters in lipedema patients, indirectly relevant to the metabolic protection aspect of the question, but it does not directly test whether gynoid/peripheral fat distr
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created
- 2026-06-12 — stance corrected · R-AI-14 audit: evidence stance context→supporting (adopted from independent verifier).